Oncology
Your platform for extensive breast cancer analysis and research – Explore LynxCare’s Breast Cancer Datasets
67% stage I-II breast cancer patients, 14% stage III-IV breast cancer patients - discover more LynxCare datasets insights.
The Breast Cancer datasets within LynxCare's European hospital network exemplify our commitment to qualitative, fast, and comprehensive data solutions.
The vast and validated datasets* developed from EU electronic health records provide a robust platform for extensive analysis and research, offering valuable insights into patients battling breast cancer.
Our datasets in numbers:
- 4800+: estimated number of breast cancer patients currently in our datasets (prior to inclusion/exclusion criteria)
- 598: the number of endpoints measured with high level of completeness as a result of disease-specific NLP, offering exceptional granularity for analysis
- 67%: percentage of patients with breast cancer in stage I-II
- 56%: percentage of stage I breast cancer patients with mastectomy
- 9.8%: percentage of triple negative breast cancer patients
With these statistics only being a sneak peek into LynxCare's comprehensive dataset, explore the breadth and depth of our datasets.
➡ CLICK HERE
* LynxCare datasets concern datasets within the LynxCare hospital network. The hospitals are the data controllers. No commitment before site approval on RWE request.
